scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1038/NCPENDMET1050 |
P698 | PubMed publication ID | 19165223 |
P2093 | author name string | Bu B Yeap | |
P2860 | cites work | Testosterone and Cardiovascular Risk in Men: A Systematic Review and Meta-analysis of Randomized Placebo-Controlled Trials | Q22305464 |
A Population-Level Decline in Serum Testosterone Levels in American Men | Q22306213 | ||
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 | ||
The decline of androgen levels in elderly men and its clinical and therapeutic implications | Q28251483 | ||
Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement | Q28272968 | ||
Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging | Q31831299 | ||
Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis | Q33222142 | ||
Endogenous sex hormones in men aged 40-80 years | Q33974189 | ||
Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study | Q34113431 | ||
Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study | Q34177963 | ||
Clinical review 171: The rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations | Q34357114 | ||
Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations | Q34493890 | ||
Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis | Q34502187 | ||
Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation | Q34567335 | ||
Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis | Q34604937 | ||
Recognizing rare disorders: aromatase deficiency. | Q34621892 | ||
In men older than 70 years, total testosterone remains stable while free testosterone declines with age. The Health in Men Study | Q34623954 | ||
Testosterone and estradiol among older men. | Q46861767 | ||
Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study | Q46881122 | ||
Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada. | Q46892538 | ||
Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men. | Q46947824 | ||
Secular decline in male testosterone and sex hormone binding globulin serum levels in Danish population surveys | Q46982075 | ||
Higher serum free testosterone is associated with better cognitive function in older men, while total testosterone is not. The Health In Men Study | Q46987675 | ||
Use, misuse and abuse of androgens. The Endocrine Society of Australia consensus guidelines for androgen prescribing | Q48723482 | ||
A critical evaluation of simple methods for the estimation of free testosterone in serum | Q49081910 | ||
Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males | Q49100770 | ||
Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. | Q50961169 | ||
Low levels of sex hormone-binding globulin and testosterone are associated with smaller, denser low density lipoprotein in normoglycemic men. | Q51002112 | ||
Endogenous sex hormones and ischemic heart disease in men. The Caerphilly prospective study. | Q51059132 | ||
Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the Strong Heart Study. | Q51756663 | ||
Association of Testosterone and Estradiol Deficiency with Osteoporosis and Rapid Bone Loss in Older Men | Q56110089 | ||
SHBGGene Promoter Polymorphisms in Men Are Associated with Serum Sex Hormone-Binding Globulin, Androgen and Androgen Metabolite Levels, and Hip Bone Mineral Density | Q56110104 | ||
Usefulness of sex steroid hormone levels in predicting coronary artery disease in men | Q58217684 | ||
The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men | Q79407772 | ||
Androgens and diabetes in men: results from the Third National Health and Nutrition Examination Survey (NHANES III) | Q79678541 | ||
Insulin resistance as estimated by homeostasis model assessment predicts incident symptomatic cardiovascular disease in caucasian subjects from the general population: the Bruneck study | Q79678578 | ||
Relationship between BMI, total testosterone, sex hormone-binding-globulin, leptin, insulin and insulin resistance in obese men | Q80008221 | ||
The effect of changes in adiposity on testosterone levels in older men: longitudinal results from the Massachusetts Male Aging Study | Q80129104 | ||
Sex steroids and all-cause and cause-specific mortality in men | Q80528328 | ||
The androgen receptor mRNA. | Q35788444 | ||
Gonadal dysfunction in systemic diseases | Q36092338 | ||
Low serum testosterone and mortality in older men. | Q36360750 | ||
Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials | Q36486895 | ||
Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline | Q36486899 | ||
Correlations between serum testosterone, estradiol, and sex hormone-binding globulin and bone mineral density in a diverse sample of men | Q36732699 | ||
Aging and hormones of the hypothalamo-pituitary axis: gonadotropic axis in men and somatotropic axes in men and women | Q36973105 | ||
Non-classical actions of testosterone: an update. | Q36998637 | ||
Association between hormones and metabolic syndrome in older Italian men. | Q37122014 | ||
Age-related changes in serum testosterone and sex hormone binding globulin in Australian men: longitudinal analyses of two geographically separate regional cohorts | Q39802392 | ||
Endogenous sex hormones and incident fracture risk in older men: the Dubbo Osteoporosis Epidemiology Study. | Q40134234 | ||
Low serum testosterone and high serum estradiol associate with lower extremity peripheral arterial disease in elderly men. The MrOS Study in Sweden | Q40176293 | ||
Prevalence of symptomatic androgen deficiency in men. | Q40183474 | ||
Prevalence of and risk factors for androgen deficiency in middle-aged men in Hong Kong | Q40278382 | ||
The natural history of symptomatic androgen deficiency in men: onset, progression, and spontaneous remission | Q41397151 | ||
Bioavailable testosterone and depressed mood in older men: the Rancho Bernardo Study | Q41607274 | ||
Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo | Q41673149 | ||
A prospective study of sex hormone-binding globulin and fatal cardiovascular disease in Rancho Bernardo men and women | Q43748164 | ||
Sex hormones and age: a cross-sectional study of testosterone and estradiol and their bioavailable fractions in community-dwelling men. | Q43837276 | ||
Endogenous sex hormones and cardiovascular disease incidence in men. | Q43838976 | ||
Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study | Q43843236 | ||
Lifestyle and nutritional determinants of bioavailable androgens and related hormones in British men. | Q44034900 | ||
Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study | Q44089025 | ||
Endogenous hormones and carotid atherosclerosis in elderly men. | Q44265354 | ||
The metabolic syndrome, insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients | Q44496541 | ||
Aging, androgens, and the metabolic syndrome in a longitudinal study of aging | Q44525492 | ||
The associations of age, lifestyle factors and chronic disease with testosterone in men: the Tromsø Study. | Q44529969 | ||
Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. | Q44685104 | ||
Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat. | Q44816778 | ||
Endogenous sex hormones and progression of carotid atherosclerosis in elderly men. | Q44851044 | ||
Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. | Q44865591 | ||
Waist circumference and testosterone levels in community dwelling men. The Tromsø study | Q45087781 | ||
Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. | Q45168742 | ||
Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study | Q45173585 | ||
Sex hormone-binding globulin and insulin-like growth factor-binding protein-1 as indicators of metabolic syndrome, cardiovascular risk, and mortality in elderly men. | Q45197429 | ||
Serum androgen levels in black, Hispanic, and white men. | Q45215454 | ||
Endogenous sex hormones and metabolic syndrome in aging men. | Q45248596 | ||
Low serum testosterone and mortality in male veterans | Q45332648 | ||
Healthier lifestyle predicts higher circulating testosterone in older men: the Health In Men Study | Q45815116 | ||
Increased carotid atherosclerosis in andropausal middle-aged men. | Q46489664 | ||
Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. | Q46570705 | ||
Lower sex hormone-binding globulin is more strongly associated with metabolic syndrome than lower total testosterone in older men: the Health in Men Study | Q46573387 | ||
Cortisol, testosterone, and coronary heart disease: prospective evidence from the Caerphilly study | Q46595113 | ||
Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip. | Q46595277 | ||
The association of sex hormone levels with poor mobility, low muscle strength and incidence of falls among older men and women | Q46629445 | ||
Low testosterone levels are common and associated with insulin resistance in men with diabetes. | Q46719146 | ||
Low free testosterone concentration as a potentially treatable cause of depressive symptoms in older men. | Q46721060 | ||
Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study | Q46757585 | ||
Testosterone, dehydroepiandrosterone, and physical performance in older men: results from the Massachusetts Male Aging Study | Q46839525 | ||
P433 | issue | 2 | |
P921 | main subject | testosterone | Q1318776 |
testosterone | Q27863114 | ||
P304 | page(s) | 113-121 | |
P577 | publication date | 2009-02-01 | |
P1433 | published in | Nature Clinical Practice Endocrinology and Metabolism | Q15750240 |
P1476 | title | Testosterone and ill-health in aging men. | |
P478 | volume | 5 |
Q38695918 | A Reappraisal of Testosterone's Binding in Circulation: Physiological and Clinical Implications. |
Q36370472 | A cross-sectional study of the association of age, race and ethnicity, and body mass index with sex steroid hormone marker profiles among men in the National Health and Nutrition Examination Survey (NHANES III) |
Q40848557 | Associations Between Sex Hormone Levels and Periodontitis in Men: Results From NHANES III. |
Q38555904 | At what price do we treat patients with testicular cancer? |
Q92168407 | Beyond the challenge hypothesis: The emergence of the dual-hormone hypothesis and recommendations for future research |
Q37134718 | Causes, consequences, and treatment of osteoporosis in men. |
Q36911460 | Circulating Sex Steroids and Vascular Calcification in Community-Dwelling Men: The Framingham Heart Study |
Q33559688 | Circulating brain-derived neurotrophic factor and indices of metabolic and cardiovascular health: data from the Baltimore Longitudinal Study of Aging |
Q46280980 | Coenzyme Q10 and fish oil synergistically alleviate aluminum chloride-induced suppression of testicular steroidogenesis and antioxidant defense |
Q35624509 | Diagnosis and treatment of sexual dysfunctions in late-onset hypogonadism |
Q46907767 | Dihydrotestosterone treatment delays the conversion from mild cognitive impairment to Alzheimer's disease in SAMP8 mice |
Q33801088 | Distinct roles of age and abdominal visceral fat in reducing androgen receptor-dependent negative feedback on LH secretion in healthy men. |
Q38055249 | Do low testosterone levels contribute to ill-health during male ageing? |
Q36847461 | Effects of epsilon4 on object recognition in the non-demented elderly |
Q34405392 | Endogenous testosterone and mortality in male hemodialysis patients: is it the result of aging? |
Q37681039 | Expansion of mossy fibers and CA3 apical dendritic length accompanies the fall in dendritic spine density after gonadectomy in male, but not female, rats |
Q48067671 | Fatigue in male lymphoma survivors differs between diagnostic groups and is associated with latent hypothyroidism |
Q37756967 | Growth hormone and testosterone in heart failure therapy |
Q41270677 | Hormonal dysfunction is frequent in cancer survivors treated with radiotherapy to the head and neck region |
Q34185801 | Insulin Resistance is an Independent Correlate of High Serum Levels of Advanced Glycation End Products (AGEs) and Low Testosterone in Non‐Diabetic Men |
Q35015351 | Long-term Safety of Testosterone and Growth Hormone Supplementation: A Retrospective Study of Metabolic, Cardiovascular, and Oncologic Outcomes |
Q47239998 | Long-term toxicity of cisplatin in germ-cell tumor survivors. |
Q60302984 | MR-10 Enhances Men's Health by Improving Endogenous Male Sex Hormone Generation |
Q37982443 | Minimizing toxicity in early-stage testicular cancer treatment |
Q39539632 | Modulating testosterone pathway: a new strategy to tackle male skin aging? |
Q45173012 | Obesity and age as dominant correlates of low testosterone in men irrespective of diabetes status. |
Q48239845 | Serum testosterone levels in male hypogonadism: Why and when to check-A review |
Q50067073 | Sex Determines Cardiac Myocyte Stretch and Relaxation |
Q34039684 | Testicular cancer survivorship: research strategies and recommendations |
Q37593729 | Testosterone deficiency syndrome and cardiovascular health: An assessment of beliefs, knowledge and practice patterns of general practitioners and cardiologists in Victoria, BC. |
Q37013602 | Testosterone depletion in adult male rats increases mossy fiber transmission, LTP, and sprouting in area CA3 of hippocampus |
Q51509768 | Testosterone increases renal anti-aging klotho gene expression via the androgen receptor-mediated pathway. |
Q38641840 | The complex and multifactorial relationship between testosterone deficiency (TD), obesity and vascular disease |
Q37302806 | The heritability of circulating testosterone, oestradiol, oestrone and sex hormone binding globulin concentrations in men: the Framingham Heart Study |
Q40953550 | The relationship between testosterone deficiency and frailty in elderly men. |
Q34022211 | The role of adipose tissue and adipokines in obesity-related inflammatory diseases |
Q40906646 | Vitamin D is significantly associated with total testosterone and sex hormone-binding globulin in Malaysian men. |
Search more.